Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver
β Scribed by Masayuki Shiraishi; Yasukatsu Takushi; Hiroaki Simoji; Takeshi Oshiro; Sanae Shinzato; Noboru Tanigawa; Toshiomi Kusano; Yoshihiro Muto
- Publisher
- Springer Japan
- Year
- 1998
- Tongue
- English
- Weight
- 509 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
An assessment was made of the frequency of liver cell dysplasia and the mean age of each group in 56 normal, 13 cirrhotic, and 50 hepatocellular carcinoma (HCC) patients, 40 with cirrhosis, from southern Africa. Dysplasia increased from 7.1% in normal subjects to 38.5% in cirrhotic, 40% in noncirrho
## Abstract Abberrant DNA methylation is one of the hallmarks of cancerogenesis. Our study aims to delineate differential DNA methylation in cirrhosis and hepatic cancerogenesis. Patterns of methylation of 27,578 individual CpG loci in 12 hepatocellular carcinomas (HCCs), 15 cirrhotic controls and
Galectins are a family of β€-galactoside-binding animal lectins. In particular, a widely studied member galectin-3, previously designated as βBP, CBP35, Mac-2, L-29 and L-34, has been associated with assorted processes such as cell growth, tumor transformation and metastasis. Galectin-3 is expressed